Marketresearchnews

Sunday, 30 August 2020

Recent Study Explores Cardiac Monitoring and Cardiac Rhythm Management Device Market Pipeline Review, 2019

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Cardiac Monitoring and Cardiac Rhythm Management Device Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

The Global Cardiac Monitoring And Cardiac Rhythm Management Device Market is to escalate as incidences of cardiovascular disorders surge states Market Research Future (MRFR). The report published by MRFR on the cardiac monitoring and cardiac rhythm management device market mentions that the market can garner a CAGR of approximately 4% from 2018 to 2023.

Market Overview

The growing cases of arrhythmias is likely to increase the adoption of cardiac monitoring and cardiac rhythm management devices in several healthcare organizations. The diagnostic centers, hospitals, and clinics are widely using the devices as they provide precise results. The growing significance of the devices in management of other cardiac problems like atrial flutter, atrial fibrillation, and heart failure is also surging the devices popularity. The devices also aid in the early detection of heart attack, diagnose the lack of oxygen supply to heart muscle, and even, genetic errors. Hence, these can prompt the market growth.

Other factors like, changing lifestyle with high calorie consumption and lack of exercises, technical development backing medical advancements, wide spreading awareness of updated medical treatment and diagnostic solutions, and increase in the need for effective treatment can shoot up the cardiac monitoring and cardiac rhythm management device market growth curve over the review period.

Also Read : https://www.globenewswire.com/news-release/2019/07/29/1892638/0/en/Cardiac-Monitoring-and-Cardiac-Rhythm-Management-Device-Market-Eyeing-Admirable-Growth-Due-to-Increasing-Prevalence-of-Cardiovascular-Diseases.html

On the flip side, the high expenses associated with the devices, people opting for drugs over these devices, and limited insurance coverage can hinder the global cardiac monitoring and cardiac rhythm management device market g owth.

Competitive Analysis

MRFR profiled some of the eminent key players operating in the global cardiac monitoring and cardiac rhythm management device market. They are; Abbott, Berlin Hearth, Abiomed, Boston Scientific Corporation, Brotionik SE and Co. KG, Cardiac Science Corporation, Hill Rom Services Inc, General Electric(GE), Medtronic plc, and Schiller.

Segmentation

The global cardiac monitoring and cardiac rhythm management device market study has been segmented on the basis of cardiac monitoring devices, cardiac device, cardiac rhythm management device, and end-user.

Based on the cardiac monitoring devices, the market has been segmented into Implantable Loop Recorder, Holter Monitor, Electrocardiogram (ECG), Event Monitor, and Cardiac Output Monitoring Devices. The Electrocardiogram segment has been further classified into Wireless ECG, Telelectro-Cardiogram, and Lead ECG.

Based on the cardiac device, the market has been segmented into, Biventricular Pacemaker, Pacemaker, Implantable Cardiac Loop Recorder, and Implantable Cardioverter Defibrillator.

Based on the cardiac rhythm management device, the market has been segmented into Defibrillators, Cardiac Resynchronization Therapy Devices, and Pacemakers. The Defibrillators segment has been narrowed down to External Defibrillators and Implantable Defibrillators.

Based on the end-use, the market has been segmented into Ambulatory Surgical Centers, Hospitals, and others.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/cardiac-monitoring-advance-technologies-global-market-6332

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

EClinical Solutions Market Segments, Opportunity, Growth And Forecast By End-Use Industry 2019

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “eClinical Solutions Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

According to Market Research Future (MRFR)’s assessment, the global eClinical solutions market is expected to touch a valuation of USD 9434.57 Mn by the end of the forecast period (2018 to 2023) striking a robust CAGR of 12.24%. The growth of the pharmaceutical industry is poised to support the expansion of the market over the next couple of years.

The increasing patient population, in conjunction with the rising burden of chronic diseases, has led to a drastic rise in research & development for drug discovery. This, in turn, is projected to propel the expansion of the eClinical solutions market in the years to come. In addition, investments being made into clinical trials are also projected to influence the growth pattern of the market positively in the nearby future.

The eClinical solutions market is anticipated to witness boom owing to its extensive use during clinical trials for decision making and enhancing efficiency. It also helps in reducing the costs of the trials which is expected to act as a growth catalyst for the market.

Also Read : http://www.globenewswire.com/news-release/2019/06/10/1866344/0/en/eClinical-Solutions-Market-is-set-to-Witness-a-CAGR-of-12-24-Is-Set-to-Reach-USD-9434-57-million-By-2023-End-Says-Market-Research-Future.html

Key Players:

The prominent players of eClinical solutions market profiled in this report are ERT Clinical, BioClinica, Inc., PAREXEL International Corporation, CRF Health, DATATRAK International, Inc., Oracle Corporation, Merge Healthcare Inc, Omnicomm Systems, Inc., Medidata Solutions, Inc., and MaxisIT.

Market Segmentation:

This MRFR report covers an exhaustive segmental analysis of the global eClinical solutions market based on type, delivery mode, clinical trial phase, and end-user. By type, the market is segmented into Clinical Data Management System (CDMS), Randomization and Trial Supply Management (RTSM), Electronic Clinical Outcome Assessment (eCOA), Clinical Trial Management System (CTMS), Electronic Trial Master Files (eTMF), and trial safety & regulatory. Among these, the Clinical Data Management System (CDMS) segment is projected to hold the dominant share of the market and reach a valuation of USD 2579 Mn by the end of the assessment period. On the other hand, the electronic clinical outcome assessment (eCOA) segment is anticipated to expand at a higher CAGR of 14.98% during the forecast period.

Based on delivery mode, the eclinical solutions market has been bifurcated into web-based and cloud-based, and enterprise-based.

The market, by clinical trial phase, has been segmented into phase I, phase II, and others.

On the basis of end-user, the market has been bifurcated into Contract Research Organizations (CROs), and pharma/biotech companies.

Americas to retain its forefront position in the global marketplace

The regional assessment of the global eClinical Solutions Market spans across Americas, Europe, Asia Pacific, and the Middle East & Africa (MEA). Americas accounted for the largest share of the market in 2017 which accounted for 47.99% share. It is projected to strike a robust CAGR of 12.41 % over the assessment period. The U.S. is projected to lead the growth of the regional market in the upcoming years. On the other hand, Canada is poised to exhibit tremendous potential and expand at a relatively higher CAGR of 9.98% across the review period.

Asia Pacific signifies immense growth potential and is likely to exhibit a steep rise in the growth curve. The presence of a vast patient population, in conjunction with increasing outsourcing of clinical trials, is anticipated to catapult the eClinical solutions market in the region on an upward trajectory. In addition, the rising geriatric population is another major factor expected to propel the expansion of the regional market in the years to come. India is expected to dictate the growth of the eclinical solutions market in the region trailed by China and Japan.

Latest Industry Trends:

OmniComm Systems, Inc., a renowned provider of clinical data management technology, hosted Innovation Forum Asia with patient-centric eClinical solutions, drug innovations, and the latest trends in pharmaceutical research as the primary agenda.
ClinCapture, Inc., a leading eClinical software company, announced that its integrated Captivate Platform has resulted in a record number of new customers.
An eClinical software as a service (SaaS) company, Medrio, has partnered with a provider of cloud-hosted services, Adaptive Clinical Systems, for expanding integration options between the Medrio platform and other eClinical systems.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/eclinical-solution-market-2294

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Lancet Market Dynamics, Forecast, Analysis And Supply Demand 2019

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Lancet Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

Market Overview

As per a report made available by Market Research Future, the Lancet Market is expected to expand at a CAGR of 10.50% in the upcoming forecast period. Diabetes is identified as one of the most prevalent ailments plaguing society over the past few decades. The need to constantly monitor blood glucose levels is motivating the market for lancets. As most of the lancets are single-use items and are disposed off after use, they are witnessing a stable demand curve which is expected to rise considerably.

The increasing preference for home testing kits is expected to play a significant role in the development of the market. The ease of use of blood glucose testing strips is anticipated to improve the share of the market in the coming years. The increased adaptability of advanced technology related to the use of test strips is motivating the development of the lancet market globally. The presence of a well-educated user base is an instrumental aspect that is likely to motivate the market for lancets greatly in the coming period.

Also Read : https://www.globenewswire.com/news-release/2019/07/30/1893755/0/en/Lancet-Market-Size-Is-Estimated-To-Grow-at-a-CAGR-of-10-50-By-2024-Predicts-Market-Research-Future.html

Competitive Analysis

The prime contenders in the global lancet market are Bayer AG (Germany), HTL-STREFA S.A. (Poland), Sarstedt AG & Co. (Germany), Terumo Corporation (Japan), Becton, Dickinson and Company (US), Greiner Bio-One International GmbH (US), Abbott Laboratories (US), F. Hoffmann-La Roche Ltd (Switzerland), Improve Medical Instruments Co. Ltd (US) and others.

Segmentation

The segmental assessment of the Lancet Market is carried out on the basis of type, end-user, and region.

On the basis of type, the market has been segmented into personal lancet and safety lancet. The safety lancets segment can be further segmented into pressure activated safety lancets, push-button safety lancets, and side button safety lancets. On the basis of end user, the market is segmented into diagnostic centers & pathology laboratories, the hospitals & clinics, research and academic laboratories, home diagnostics, and others. The hospitals & clinics segment holds a key share of the market globally.

Regional Analysis

The Global Lancet Market, based on region, is divided into Europe, the Americas, Asia-Pacific, and the Middle East and Africa.

Europe held the largest share of the global lancet market. The Europe market demonstrated substantial growth in the market due to the growing demand and need for safe blood glucose tests in hospitals, clinics, diagnostics centers, etc. and the growth in insulin users. The Americas held a substantial share in the global lancet market owing to the rise in the prevalence of diabetes and the increasing need for a diabetes diagnosis.

Asia-Pacific was the fastest growing region in the global market and accounted for 19.1% market share in the global market in 2018. The growth in this region is attributed to the low manufacturing cost and low labor cost in the region. Moreover, the Middle East and Africa showed the least growth owing to low per capita income and lack of adequate healthcare spending.

Key Updates

Ascensia Diabetes Care, known for its CONTOUR™ variety of blood-glucose monitoring system, is expanding its offerings. One of the newest Contour products is the Bluetooth-enabled CONTOUR NEXT ONE, which links the CONTOUR Diabetes app through a smartphone. The app permits the person to monitor their blood glucose values and log what they’ve eaten or how they’ve exercised.

LifeScan, recognized for its blood glucose monitoring meters and test strips, recently announced an arrangement with Sanvita Medical to shift into continuous glucose monitoring (CGM), which is expected to become the standard of care for the huge majority of people with diabetes who don’t use insulin. LifeScan’s OneTouch brand of blood glucose testing strips, meters, lancets, and point-of-care systems are well popular among distinct consumer bases and hospitals.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/lancet-market-2078

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Genetic Testing Market Trends, Size And Growth Analysis 2019 To 2023

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Genetic Testing Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

Genetic testing is a procedure which tests for changes in a gene, DNA sequences, or chromosome structures. This allows physicians to get an idea of which genetic diseases the individual may be suffering from or may be at risk of contracting. Genetic testing consists of a series of lab tests that identify variants in the gene structure and identify risk-causing variants that can lead to certain diseases. This type of testing for diseases is fairly new and has become vitally important in the healthcare sector due to the growing prevalence of several genetic diseases. The growing awareness about the role played by genetic components in various other diseases has also helped the growth prospects of the genetic testing market. While diseases such as CVDs, asthma, cancer, and diabetes may not be caused by genetic factors, there is often a link with the genetic makeup of the individual that marks out the individual as being at risk from the respective disease. This has driven interest in genetic testing.

Also Read : https://www.medgadget.com/2020/02/genetic-testing-market-driven-by-growing-prevalence-of-cancer.html

Some of the major applications of genetic testing include:

Cancer:

Genetic testing has become a key tool for diagnosing and preventing cancer. Genetic testing looks for specific inherited changes (variants) in a person’s genetic structure. These variants can be malignant or benign, depending upon their respective structure. Cancers can result from a few types of malignant variants, which increase the risk of contracting certain types of cancer. Cancer can sometimes be seen to be “running in a family”, with multiple individuals from the same family falling prey to the same type of cancer. This is associated with the aforementioned variants, which can congenitally increase the risk of certain types of cancer in some people. Genetic testing allows physicians to discover these variants and then take the respective action to either delay or tackle the cancer. Many of the genetic anomalies responsible for causing cancer have been identified, which gives strength to this application of genetic testing.

The growing awareness about cancer and genetic testing is likely to be a major driver for the global genetic testing market. Cancer has become one of the major healthcare concerns in modern times, with cancer figures rising across the world and more people falling prey to it than ever before. This has driven interest in effective medical methodologies that can identify cancer risk early on, allowing the patient to treat and handle cancer at their own terms. The increasing popularity of direct to consumer genetic testing kits has also helped people stay on top of their cancer, as this has enabled easy and early identification of cancer, allowing effective medication and treatment. This is likely to be a major driver for the global genetic testing market over the coming years.

Reproductive Health:

Another strong application channel for genetic testing technology includes prenatal and newborn testing to find out whether the newborn is at risk from any genetic diseases. In fact, in this case, genetic testing begins pre-birth, with genetic testing allowing parents to know if the fetus is suffering or is likely to suffer from certain genetic conditions. This has become a major weapon for physicians dealing with newborns, as genetic testing allows them to formulate specifically tailored treatment and management regimens for specific genetic diseases. The increasing awareness about fetal and newborn testing is likely to be a major driver for the global genetic testing market over the forecast period.

Genealogy and Ancestry:

With the advent of direct to consumer genetic testing kits, genealogy has become of interest to an increasing number of people, who look to use the ease of genetic testing to find out more about who they are and who they are descended from. According to the CDC, genealogy has become the second most popular habit in the U.S., following only gardening. This is also likely to be a major demand driver for the global genetic testing market in the coming years.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/genetic-testing-market-2009

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

CBD (Cannabidiol) Market Revenue, Opportunity, Forecast And Value Chain Analysis 2026

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “CBD (Cannabidiol) Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

Market Research Future (MRFR) collected data on several factors including implications of covid-19 outbreak on Global CBD (Cannabidiol) Market 2020 and demographic challenges, showed how it could move forward in the coming years.

CBD (Cannabidiol) Market Overview

Cannabidiol (CBD) is a natural compound present in the cannabis resinous flower, a plant with a long history as a medicinal drug stretching back several decades. Today scientists and physicians around the world are researching and verifying the medicinal effects of CBD. CBD is one of over a hundred “phytocannabinoids,” a healthy, non-addictive drug that is specific to cannabis and that endows the plant including its robust medicinal profile. CBD is closely linked to another essential phytocannabinoid involved in the medicine: tetrahydrocannabinol (THC), the compound that induces the high medical marijuana is known for.

Also Read : https://www.medgadget.com/2020/05/covid-19-outbreak-impact-on-cbd-cannabidiol-market-2020-global-industry-analysis-size-growth-pricing-new-developments-top-companies-key-region-forecast-to-2026.html

CBD and THC both have great medicinal strengths. Unlike THC, however, CBD doesn’t really make someone feel intoxicated. This is because CBD and THC function on various brain receptors and bodies in differing ways. Indeed, CBD will mitigate or neutralize THC’s addictive properties, based on how much each compound is consumed. Most people like cannabis without the high-or with a little less a high-health benefit. The idea that CBD is both medicinally active and non-intoxic, and easier to take as a CBD oil, makes it an attractive treatment choice for those that try it for the first time.

There’s plenty of hype about CBD’s healing abilities-for justifiable reason. But that wasn’t this until June 2018. Food and Drug Administration (FDA) has accepted cannabidiol as a true medication by recognizing Epidiolex, an almost pure form of prescription CBD, as a cure for two serious pediatric seizure disorders, Lennox-Gastaut syndrome and Dravet syndrome. It was the first time since the height of the reefer madness era 80 years ago – as “marihuana” was a felony rather than a treatment – that the administration gave an official thumbs-up for a drug extracted from cannabis.

CBD Market Key Players

The prominent players in the global CBD market are Aphria Inc., Folium Biosciences, Freedom Leaf, Inc, Green Roads of Florida, LLC, CBD Health Solutions, LLC, ENDOCA, Isodiol International Inc, CV Sciences, Inc, Medical Marijuana, Inc., Canopy Growth Corporation, Elixinol Global Limited.

CBD (Cannabidiol) Market Segmentation

CBD is not a wonder but a substance. Most people may greatly benefit from legal access to a wide variety of cannabis treatments, not just low-THC or no-THC products. CBD alone can not do the trick at all. There is ample evidence that CBD performs best when combined with THC and the wide range of other ingredients of cannabis. In order to understand the global CBD market in a better way, experts have segmented the market.

Based on form, the market has been segmented into:

Solid
Liquid

By product:

Food Grade
Therapeutic Grade

By routes of administration:

Tincture
Capsules
Inhalation (Smoke or Vapor)
Aerosol Spray

By application:

Fibromyalgia
Neurogenerative Disorder
Diabetes
Energy Drinks
Protein Bars

By end user:

Food & Beverage
Healthcare

By source:

Organic
Inorganic

CBD (Cannabidiol) Market Regional Overview

These are of course exciting times for the CBD industry. Experts believe that CBD’s future looks bright, with big international retailers willing to store a wider variety of CBD items. That being said, sounding a cautionary note is essential. Big, scientific studies are still in dearth, and several questions need to be answered. To better understand the global market for CBD at regional levels, industry experts have segmented the market based on regions which include North America, Asia Pacific, Europe, and the rest of the world. The countries covered in the report are India, China, the United States, the United Kingdom, Australia, Japan, Germany, and others.

CBD (Cannabidiol) Industry News

Newly implemented government plans for tribal hemp development are giving a strategic advantage to US sovereign countries in cultivating the plant and selling CBD, the communities claim. Following 80 years of ban, when U.S. farmers race to grow hemp, tribal territorial authorities realize they have such an edge so they can avoid red tape to become the first merchants on state markets to sell very own CBD.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/cbd-market-8090

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Oncology Information Systems Market 2019 Share, Trend, Segmentation And Forecast To 2023

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Oncology Information Systems Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

Global Oncology Information Systems Market 2020, Research Report, Size, Share, Growth and Industry Analysis by Product & Service Type (Software, Professional Services), Application (Medical Oncology, Radiation Oncology, Surgical Oncology), End User (Hospitals & Oncology Clinics) – Forecast Till 2023

Oncology Information Systems Market Analysis

Global oncology information systems marketis likely to grow at a 7.5% CAGR between 2018-2023, reveals the new Market Research Future (MRFR) report. The oncology information system, simply put, is a complete information & image management solution that helps to manage patient treatment schedules, treatment summaries, treatment delivery, and treatment plans. Owing to its excellent features and multiple benefits, the oncology information systems find wide applications in surgical oncology, radiation oncology, and medical oncology, among others.

Also Read : https://www.medgadget.com/2020/04/oncology-information-systems-market-to-grow-at-7-5-cagr-by-2023-americas-to-lead-global-market.html

Numerous factors are adding to the oncology information systems market demand. Such factors, as revealed by the latest MRFR report, include technological advances in these systems, rising investments in cancer research, increasing incidence of cancer, and growing geriatric population worldwide.

On the contrary, higher costs of oncology information systems may limit the oncology information systems market growth over the forecast period.

Oncology Information Systems Market Segmentation

The Market Research Future Report provides an inclusive segmental analysis of the oncology information systems market based on end user, application, and product & service type.

By product & service type, the oncology information systems market is segmented into professional and software services. The software segment is again segmented into treatment planning systems and patient information systems. Professional services are again segmented into post-sale and maintenance services, implementation services, and consulting/optimization services. Of these, software services will lead the market over the forecast period.

By application, the oncology information systems market is segmented into surgical oncology, radiation oncology, and medical oncology. Of these, medical oncology will dominate the market over the forecast period.

By end user, the oncology information systems market is segmented into research centers, government institutes, hospitals and oncology clinics, and others. Of these, hospitals and oncology clinics will have a major share in the market over the forecast period.

Oncology Information Systems Market Regional Analysis

By region, the global oncology information systems market covers the growth opportunities and recent trends across Europe, the Americas, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will lead the market over the forecast period for the higher adoption of services or devices that are technologically advanced, presence of well-established healthcare infrastructure, rising prevalence of cancer, and presence of top market participants in the region.

The oncology information systems market in Europe is predicted to have favorable growth over the forecast period for increasing prevalence of cancer coupled with growing adoption and usage of healthcare IT in Italy, Spain, France, Germany, and the UK.

The oncology information systems market in the APAC region is predicted to grow at a high CAGR over the forecast period. Factors adding to the growth of the oncology information systems market in the region include the growing awareness about these systems in Australia, Japan, China, and India, the rising prevalence of cancer, and the presence of geriatric population base.

The oncology information systems market in the MEA will have a small share over the forecast period. The Middle East is predicted to have a major share in the market for improving quality healthcare. The healthcare sector in the region is constantly changing, and the rapidly developing technological landscape is likely to shape the healthcare sector in the upcoming years.

Oncology Information Systems Market Key Players

Key players profiled in the global oncology information systems market report include CureMD Healthcare, Bogardus Medical Systems, Inc., Epic Systems Corporation, RaySearch Laboratories, Flatiron Health, Inc., Varian Medical Systems, Inc., Varian Medical Systems, Inc., Altos Solutions, Inc., Elekta AB, McKesson Corporation, Cerner Corporation, Philips Healthcare, and Accuray Incorporated.

Oncology Information Systems Industry News

March 2020: Sanofi has finally received the first FDA nod for its myeloma medicine, Sarclisa, in a decade for a wholly-owned oncology medicine.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/oncology-information-systems-market-7080

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Coronary Stents Market To Observe Significant Growth By 2019

Market Research Future With Their Unique Quality Of Simplifying The Market Research Study, Announces A Deep Study Report On “Coronary Stents Market Research Report – Forecast To 2023” Gives Industry Size, Top Players And Worldwide Demand

Global Coronary Stents Market 2020 Market Research Report is spread across 130 pages and provides exclusive vital statistics, data, information, trends and competitive landscape details in this niche sector.

Coronary Stents Market Overview:

Global coronary stents market size in 2017 was USD9382.63 million and from there, it is expected to rise by 7.81% CAGR during the forecast period of 2018 to 2023. Market Research Future (MRFR) predicts that a major coronary stents market share would come from the Asia Pacific region due to their healthcare revamping. They also discussed several market factors like growing acceptance of the prosthesis, reduction in early complications, rising cases with heart conditions, and others as major thrust-provider.

Also Read : https://www.medgadget.com/2020/05/coronavirus-covid-19-business-impact-on-coronary-stents-market-2020-global-industry-growth-rate-demand-insights-top-company-profiles-key-regions.html

However, the coronary stents market may suffer from its high cost where the disposable income rate is not high and reimbursement policies are not favorable. In developing countries of the Asia Pacific and Latin America, and the poor economies of the Middle East & Africa, this may emerge as a problem.

Coronary Stents Market Segmentation:

The global coronary stents market report, as discussed by MRFR experts, has been segmented into products, and end user. This attempt reveals various factors and dynamics that can be studied to gauge better how the market may move forward in the coming days.

By products, the market report on the coronary stents reveals segments like drug-eluting stents, bare-metal stents, and bioresorbable vascular scaffolds. The drug-eluting stent segment had the largest market share in 2017. Its wider acceptance in the angioplasty procedures and better patient compliance put it far ahead than its competitor containing bare-metal stents. The bioresorbable stents segment is slated to project the fastest CAGR during the forecast period.

By end users, the detailed study of the coronary stents market includes hospitals & clinics, specialty centers, ambulatory surgical centers, and others. The hospitals & clinics segment had the largest market share in 2017. This is primarily due to the infrastructural benefits and better investment from various companies. The increasing expenditure for the ambulatory services in various developing regions can boost the market outcome substantially.

Given the debilitating impact of COVID-19 (Coronavirus) on Coronary Stents Market, companies are on the lookout for starting production lines. Get an inside look at the market prospects and its future decisions in light of the pandemic and other such unforeseen circumstances.

Coronary Stents Market Regional Analysis:

The American market would enjoy the upper hand in the coronary stents market. Infrastructural support and constant influx of finances would improve the chances of the market getting substantial change in the coming years. North America, with its better healthcare support, is expected to fare better. In South America, Brazil and Argentina will cover good grounds. However, poor economies in the region may restraint the regional market. In Europe, the market would get a boost from government initiatives to promote research and development. Also, better infrastructure would play a positive part in taking the market ahead.

Coronary Stents Market Competitive Landscape:

The global coronary stents market can be studied on the basis of strategic implementations launched by several companies like Biotronik SE & Co. KG, Abbott, B. Braun Melsungen AG, Stentys SA, C. R. Bard, Inc., Cook Medical, Boston Scientific Corporation, Meril Life Sciences, MicroPort Scientific Corporation, Elixir Medical Corporation, Medtronic plc, and Terumo Corporation. These companies have several technical moves in their arsenal that may boost the revenue-generation process. These means are mergers, coalitions, acquisitions, and others. Rising investment in the research and development sector is expected to trigger the market expansion rate. This is primarily due to the resultant launching of innovations and it will help companies in capturing markets.

Coronary Stents Industry News:

In April 2020, researchers presented a report on the TICO trial where the ticagrelor monotherapy has been shown as a provider of greater benefit in its treatment regarding drug-eluting stent (DES) for the acute coronary syndrome (ACS) than ticagrelor-based dual antiplatelet therapy. It reduces risks of adverse cardiac and cerebrovascular events by 34% and of bleeding by 44%. The coming years may find better acceptance of the process.

Table Of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

….Continued

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/coronary-stents-market-6938

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com